DocGo Inc’s recently made public that its Director Burdiek Michael J acquired Company’s shares for reported $21450.0 on May 15 ’25. In the deal valued at $1.43 per share,15,000 shares were bought. As a result of this transaction, Burdiek Michael J now holds 631,560 shares worth roughly $0.93 million.
Then, Klasko Stephen K. M.D. bought 15,000 shares, generating $22,350 in total proceeds. Upon buying the shares at $1.49, the Director now owns 15,000 shares.
Before that, Sugrue Stephen bought 10,000 shares. DocGo Inc shares valued at $14,400 were divested by the Chief Compliance Officer at a price of $1.44 per share. As a result of the transaction, Sugrue Stephen now holds 357,328 shares, worth roughly $0.53 million.
BTIG Research downgraded its DocGo Inc [DCGO] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who decreased its forecast for the stock in late February from “a Buy” to “a Hold”. BTIG Research began covering DCGO with “Buy” recommendation on August 18, 2023. Cantor Fitzgerald started covering the stock on April 21, 2023. It rated DCGO as “an Overweight”.
Price Performance Review of DCGO
On Friday, DocGo Inc [NASDAQ:DCGO] saw its stock jump 5.00% to $1.47. Over the last five days, the stock has gained 5.00%. DocGo Inc shares have fallen nearly -65.33% since the year began. Nevertheless, the stocks have fallen -55.45% over the past one year. While a 52-week high of $5.68 was reached on 02/18/25, a 52-week low of $1.35 was recorded on 05/12/25. SMA at 50 days reached $2.3961, while 200 days put it at $3.5479.
Levels Of Support And Resistance For DCGO Stock
The 24-hour chart illustrates a support level at 1.4100, which if violated will result in even more drops to 1.3500. On the upside, there is a resistance level at 1.5300. A further resistance level may holdings at 1.5900. The Relative Strength Index (RSI) on the 14-day chart is 26.75, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.5092, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.09%. Stochastics %K at 6.67% indicates the stock is a buying.
The most recent change occurred on April 19, 2022 when Deutsche Bank began covering the stock and recommended ‘”a Buy”‘ rating along with a $11 price target.
